Business Description
Inhibrx Biosciences Inc
NAICS : 541714
SIC : 2834
ISIN : US45720N1037
Description
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 106.99 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.01 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 29.73 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 73.02 | |||||
| 9-Day RSI | 59.9 | |||||
| 14-Day RSI | 54.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | |||||
| Quick Ratio | 4.7 | |||||
| Cash Ratio | 4.45 | |||||
| Days Sales Outstanding | 97.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 1.15 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -17775.77 | |||||
| Net Margin % | 112096.11 | |||||
| FCF Margin % | -9517.28 | |||||
| ROE % | 1854.62 | |||||
| ROA % | 1313.65 | |||||
| ROIC % | -1299.16 | |||||
| ROC (Joel Greenblatt) % | 18783.81 | |||||
| ROCE % | 1829.69 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 0.13 | |||||
| PS Ratio | 140.45 | |||||
| PB Ratio | 1.25 | |||||
| Price-to-Tangible-Book | 1.27 | |||||
| EV-to-EBIT | 0.02 | |||||
| EV-to-EBITDA | 0.02 | |||||
| EV-to-Revenue | 18.59 | |||||
| EV-to-FCF | -0.2 | |||||
| Price-to-Net-Current-Asset-Value | 1.39 | |||||
| Price-to-Net-Cash | 1.49 | |||||
| Earnings Yield (Greenblatt) % | 5000 | |||||
| FCF Yield % | -66.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:INBX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Inhibrx Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.568 | ||
| EPS (TTM) ($) | 118.674 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 54.92 | ||
| 14-Day ATR ($) | 0.881784 | ||
| 20-Day SMA ($) | 15.1875 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 10.8 - 18.95 | ||
| Shares Outstanding (Mil) | 14.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inhibrx Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inhibrx Biosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Inhibrx Biosciences Inc Frequently Asked Questions
What is Inhibrx Biosciences Inc(INBX)'s stock price today?
The current price of INBX is $15.63. The 52 week high of INBX is $18.95 and 52 week low is $10.80.
When is next earnings date of Inhibrx Biosciences Inc(INBX)?
The next earnings date of Inhibrx Biosciences Inc(INBX) is 2025-02-28 Est..
Does Inhibrx Biosciences Inc(INBX) pay dividends? If so, how much?
Inhibrx Biosciences Inc(INBX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers